Ara
Toplam kayıt 2, listelenen: 1-2
Sodium glucose co-transporter 2 inhibitors in heart failure therapy
(2020)
Sodium-glucose cotransporter-2 inhibitors (SGLT-2i) are a new class of drugs for patients with type 2 diabetes (T2DM) which inhibit urinary glucose reabsorption in the proximal tubule of the nephron and result in glucosuria, ...
Management of Hyperkalemia in Heart Failure
(2021)
Hyperkalemia is a common electrolyte abnormality in heart failure (HF) that can cause potentially life-threatening cardiac arrhythmias and sudden cardiac death. HF patients with diabetes, chronic kidney disease and older ...